Results 271 to 280 of about 102,895 (315)

Brain Neuraminidases and Gangliosides

1976
A number of data of kinetics nature indicate that brain neuraminidases (the cytosol and the membrane bound enzyme) recognize the physical state of gangliosidic substrate, with immediate modification of the activity. The interactions between the enzyme(s) and the different physical forms of the substrate are still to be studied at the molecular level ...
G, Tettamanti, B, Venerando, B, Cestaro, A, Preti   +3 more
openaire   +2 more sources

Substrate specificity of neuraminidases

The Histochemical Journal, 1973
This presentation is a brief description of neuraminidases and is mainly concerned with the substrate specificity of these enzymes. From the observed great differences in substrate specificity it is clear that we are dealing not with one enzyme called neuraminidase but with a variety of enzymes named neuraminidases.
openaire   +2 more sources

Neuraminidase-Inhibition Assay for the Identification of Influenza A Virus Neuraminidase Virus Subtype or Neuraminidase Antibody Specificity

2008
The neuraminidase-inhibition (NI) assay is a laboratory procedure for the identification of the neuraminidase (NA) glycoprotein subtype in influenza viruses or the NA subtype specificity of antibodies to influenza virus. A serological procedure for subtyping the NA glycoprotein is critical for the identification and classification of avian influenza ...
openaire   +3 more sources

[Neuraminidase inhibitor].

Nihon rinsho. Japanese journal of clinical medicine, 2001
Amantadine, effective to influenza A virus, is now widely used in Japan. Recently new anti-influenzal agents, neuramidase inhibitor has been developed. Both Zanamivir (inhaled type) and Oseltamivir(oral use), are proved to be effective in treatment of influenza A and B.
openaire   +1 more source

Neuraminidase inhibitors for influenza

BMJ, 2014
The whole truth and nothing but the truth Informed choice requires comprehensive and credible information. Much of the rationale for the currently evolving movement to fully share data is to provide information for decision making, particularly in situations involving the need to balance the potential benefits and harms of medical products.
openaire   +2 more sources

Extracellular Streptococcal Neuraminidase

Journal of Bacteriology, 1968
J K, Pinter, J A, Hayashi, A N, Bahn
openaire   +2 more sources

Mammalian sialidase (neuraminidase)

Biochemical and Biophysical Research Communications, 1960
L, WARREN, C W, SPEARING
openaire   +2 more sources

NEURAMINIDASES

1966
Max E. Rafelson, Michael Schneir, Vannie W. Wilson   +2 more
openaire   +1 more source

Neuraminidase inhibitors for influenza-like illness in primary care

Lancet, The, 2020
Nelson Lee
exaly  

[Lysosomal neuraminidase (neuraminidase-1)].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Hitoshi, Sakuraba, Kohji, Itoh
openaire   +1 more source